001     310167
005     20260303120958.0
024 7 _ |a 10.1016/j.cell.2025.12.055
|2 doi
024 7 _ |a 0092-8674
|2 ISSN
024 7 _ |a 1097-4172
|2 ISSN
037 _ _ |a DKFZ-2026-00483
082 _ _ |a 610
100 1 _ |a Meylan, Maxime
|b 0
245 _ _ |a Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
260 _ _ |a [Cambridge, Mass.]
|c 2026
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1772454208_1248508
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Tian, Ye
|b 1
700 1 _ |a Wu, Lijian
|b 2
700 1 _ |a Ling, Alexander L.
|b 3
700 1 _ |a Kovarsky, Daniel
|b 4
700 1 _ |a Barlow, Graham L.
|b 5
700 1 _ |a Nguyen, Linh D.
|b 6
700 1 _ |a Pyrdol, Jason
|b 7
700 1 _ |a Marx, Sascha
|b 8
700 1 _ |a Westphal, Lucas
|b 9
700 1 _ |a Michel, Julius
|0 P:(DE-He78)513be409835c710d4fe381543a45b410
|b 10
|u dkfz
700 1 _ |a Gonzalez Castro, L. Nicolas
|b 11
700 1 _ |a Dumont, Sydney
|b 12
700 1 _ |a Santos, Andres
|b 13
700 1 _ |a Tirosh, Itay
|b 14
700 1 _ |a Suvà, Mario L.
|b 15
700 1 _ |a Chiocca, E. Antonio
|b 16
700 1 _ |a Wucherpfennig, Kai W.
|0 0000-0002-1829-302X
|b 17
773 _ _ |a 10.1016/j.cell.2025.12.055
|g p. S0092867425015041
|0 PERI:(DE-600)2001951-8
|p nn
|t Cell
|v nn
|y 2026
|x 0092-8674
909 C O |o oai:inrepo02.dkfz.de:310167
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)513be409835c710d4fe381543a45b410
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2026
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-01
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-01
915 _ _ |a IF >= 60
|0 StatID:(DE-HGF)9960
|2 StatID
|b CELL : 2022
|d 2025-01-01
920 1 _ |0 I:(DE-He78)A014-20160331
|k A014
|l NWG Hämatologie und Immune Engineering
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A014-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21